Fernández-Chacón Macarena, Mühleder Severin, Regano Alvaro, Garcia-Ortega Lourdes, Rocha Susana F, Torroja Carlos, Sanchez-Muñoz Maria S, Lytvyn Mariya, Casquero-Garcia Verónica, De Andrés-Laguillo Macarena, Muhl Lars, Orlich Michael M, Gaengel Konstantin, Camafeita Emilio, Vázquez Jesús, Benguría Alberto, Iruela-Arispe M Luisa, Dopazo Ana, Sánchez-Cabo Fátima, Carter Hannah, Benedito Rui
Molecular Genetics of Angiogenesis Group, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain.
Faculty of Health Sciences, Universidad Loyola Andalucía, Seville, Spain.
Nat Cardiovasc Res. 2023 May 29;2:2023530-549. doi: 10.1038/s44161-023-00272-4.
The Notch pathway is a major regulator of endothelial transcriptional specification. Targeting the Notch receptors or Delta-like ligand 4 (Dll4) dysregulates angiogenesis. Here, by analyzing single and compound genetic mutants for all Notch signaling members, we find significant differences in the way ligands and receptors regulate liver vascular homeostasis. Loss of Notch receptors caused endothelial hypermitogenic cell-cycle arrest and senescence. Conversely, Dll4 loss triggered a strong Myc-driven transcriptional switch inducing endothelial proliferation and the tip-cell state. Myc loss suppressed the induction of angiogenesis in the absence of Dll4, without preventing the vascular enlargement and organ pathology. Similarly, inhibition of other pro-angiogenic pathways, including MAPK/ERK and mTOR, had no effect on the vascular expansion induced by Dll4 loss; however, anti-VEGFA treatment prevented it without fully suppressing the transcriptional and metabolic programs. This study shows incongruence between single-cell transcriptional states, vascular phenotypes and related pathophysiology. Our findings also suggest that the vascular structure abnormalization, rather than neoplasms, causes the reported anti-Dll4 antibody toxicity.
Notch信号通路是内皮细胞转录特化的主要调节因子。靶向Notch受体或Delta样配体4(Dll4)会破坏血管生成。在此,通过分析所有Notch信号成员的单基因和复合基因敲除小鼠,我们发现配体和受体调节肝脏血管稳态的方式存在显著差异。Notch受体缺失导致内皮细胞有丝分裂活性增强的细胞周期停滞和衰老。相反,Dll4缺失引发了由Myc驱动的强烈转录开关,诱导内皮细胞增殖和顶端细胞状态。Myc缺失在没有Dll4的情况下抑制了血管生成的诱导,但并未阻止血管扩张和器官病理变化。同样,抑制其他促血管生成途径,包括MAPK/ERK和mTOR,对Dll4缺失诱导的血管扩张没有影响;然而,抗VEGFA治疗可阻止血管扩张,但未完全抑制转录和代谢程序。这项研究表明单细胞转录状态、血管表型和相关病理生理学之间存在不一致。我们的研究结果还表明,血管结构异常而非肿瘤导致了报道的抗Dll4抗体毒性。